Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;6(9):2523-2524.
doi: 10.1016/j.ekir.2021.07.017. Epub 2021 Jul 27.

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine

Fadi Salem  1 , Joshua L Rein  2 , Samuel Mon-Wei Yu  2 , Mathew Abramson  2 , Paolo Cravedi  2 , Miriam Chung  2
Affiliations

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine

Fadi Salem et al. Kidney Int Rep. 2021 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a−c) Microscopic examination by light microscopy of kidney biopsy specimens from patients 1, 2, and 3, respectively, reveals relatively normal glomeruli. Periodic acid−Schiff, original magnification ×40. Bar = 50 μm (for each figure part). Immunofluorescent studies from all biopsy specimens show no evidence of immune complex deposits (not shown). (d−f) Electron microscopy examination of kidney biopsy specimens from patients 1, 2, and 3, respectively, shows diffuse effacement of foot processes of podocytes (arrows) without evidence of immune-type dense deposits. Transmission electron microscopy, original magnification ×3000. Large bar, 5 × 2 μm =10 μm (for each figure part).
See this image and copyright information in PMC

References

    1. D'Agati VD, Kudose S, Bomback AS, et al. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine [e-pub ahead of print]. Kidney Int.https://doi.org/10.1016/j.kint.2021.04.035. Accessed August 11, 2021. - DOI - PMC - PubMed
    1. Morlidge C, El-Kateb S, Jeevaratnam P, Thompson B. Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine [e-pub ahead of print]. Kidney Int.https://doi.org/10.1016/j.kint.2021.06.005. Accessed August 11, 2021. - DOI - PMC - PubMed
    1. Schwotzer N., Kissling S., Fakhouri F. Letter regarding "Minimal change disease relapse following SARS-CoV-2 mRNA vaccine. Kidney Int. 2021;100:458–459. - PMC - PubMed
    1. Bomback AS, Kudose S, D’Agati VD. De novo and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far [e-pub ahead of print]? Am J Kidney Dis.https://doi.org/10.1053/j.ajkd.2021.06.004. Accessed August 11, 2021. - DOI - PMC - PubMed

LinkOut - more resources